Discovery of 3,4-Diaminocyclobut-3-ene-1,2-dione-Based CXCR2 Receptor Antagonists for the Treatment of Inflammatory Disorders

Publisher： Bentham Science Publishers

E-ISSN： 1873-4294|10|13|1339-1350

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.10, Iss.13, 2010-09, pp. : 1339-1350

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Novel pyrimidine-based CXCR2 chemokine receptor antagonists

By  

Expert Opinion on Therapeutic Patents, Vol. 14, Iss. 10, 2004-10 ,pp. : 1507-1510

Informa Healthcare

Access to resources Recommend Favorite

Small Molecule Antagonists of the CXCR2 and CXCR1 Chemokine Receptors as Therapeutic Agents for the Treatment of Inflammatory Diseases

By  

Current Topics in Medicinal Chemistry, Vol. 6, Iss. 13, 2006-01 ,pp. : 1345-1352

Bentham Science Publishers

Access to resources Recommend Favorite

CXCR2 Receptor Antagonists: A Medicinal Chemistry Perspective

By  

Current Topics in Medicinal Chemistry, Vol. 14, Iss. 13, 2014-07 ,pp. : 1590-1605

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Progress in the Discovery of New CCR5 and CXCR4 Chemokine Receptor Antagonists as Inhibitors of HIV-1 Entry. Part 2*

By  

Current Medicinal Chemistry - Anti-Infective Agents, Vol. 4, Iss. 2, 2005-04 ,pp. : 133-152

Bentham Science Publishers

Access to resources Recommend Favorite

Structure-Based Development of Antagonists for Chemokine Receptor CXCR4

By  

Current Computer - Aided Drug Design, Vol. 9, Iss. 1, 2013-03 ,pp. : 60-75

Bentham Science Publishers

Access to resources Recommend Favorite